Literature DB >> 2233867

Fibrillation potential amplitude and muscle atrophy following peripheral nerve injury.

G H Kraft1.   

Abstract

Maximum peak-to-peak fibrillation potential amplitude was measured in 69 subjects between 7 days and 10 1/2 years post complete or partial peripheral nerve injury. Mean amplitude during the first 2 months was 612 muV; third and fourth months 512 muV, fifth and sixth months 320 muV. After the first year, no population of fibrillation potentials greater than 100 muV was recorded. The sciatic nerve was sectioned in 13 guinea pigs and animals studied up to 17 weeks. Fibrillation potential amplitude in gastrocnemius muscles declined paralleling that in humans. By the end of the study, type I fibers had lost almost half of their initial diameter and type II fibers had atrophied more than twice this amount. Fibrillation potential amplitude may be useful in estimating the time post nerve injury and appears to correlate with the surface area and fiber diameter of a type I muscle fiber.

Entities:  

Mesh:

Year:  1990        PMID: 2233867     DOI: 10.1002/mus.880130907

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  17 in total

1.  Techniques and applications of EMG: measuring motor units from structure to function.

Authors:  Rachel C Thornton; Andrew W Michell
Journal:  J Neurol       Date:  2012-01-25       Impact factor: 4.849

2.  Parsonage-Turner syndrome-case report and literature review.

Authors:  A J Hussey; C P O'Brien; P J Regan
Journal:  Hand (N Y)       Date:  2007-07-04

3.  EMG: myths and facts.

Authors:  Joseph Feinberg
Journal:  HSS J       Date:  2006-02

4.  Fibre type specific expression of Leu19-antigen and N-CAM in skeletal muscle in various stages after experimental denervation.

Authors:  W Müller-Felber; K Küllmer; P Fischer; C D Reimers; S Wagner; U Harland; M Schmidt-Achert; D Pongratz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 5.  Compressive neuropathies of the upper extremity: update on pathophysiology, classification, and electrodiagnostic findings.

Authors:  Minal Tapadia; Tahseen Mozaffar; Ranjan Gupta
Journal:  J Hand Surg Am       Date:  2010-03-11       Impact factor: 2.230

6.  Neuromuscular electrical stimulation and exercise for reducing trapezius muscle dysfunction in survivors of head and neck cancer: a case-series report.

Authors:  Evan R L Baldwin; Terri D Baldwin; Josh S Lancaster; Margaret L McNeely; David F Collins
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

7.  Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy.

Authors:  Guang-Liang Jiang; Yu-Dong Gu; Li-Yin Zhang; Li-Ying Shen; Cong Yu; Jian-Guang Xu
Journal:  ISRN Pharm       Date:  2011-08-15

8.  Interpretation of Electrodiagnostic Studies: How to Apply It to the Practice of Orthopaedic Surgery.

Authors:  Christopher J Dy; Berdale S Colorado; Andrew J Landau; David M Brogan
Journal:  J Am Acad Orthop Surg       Date:  2021-07-01       Impact factor: 4.000

9.  Identification of potential microRNAs and KEGG pathways in denervation muscle atrophy based on meta-analysis.

Authors:  Xinyi Gu; Bo Jin; Zhidan Qi; Xiaofeng Yin
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

10.  Early changes in muscle atrophy and muscle fiber type conversion after spinal cord transection and peripheral nerve transection in rats.

Authors:  Kosaku Higashino; Tetsuya Matsuura; Katsuyoshi Suganuma; Kiminori Yukata; Toshihiko Nishisho; Natsuo Yasui
Journal:  J Neuroeng Rehabil       Date:  2013-05-20       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.